featured
Concordance Between CA-125 and Radiologic Progression Is Poor in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on PARP Inhibitor Maintenance
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor
J. Clin. Oncol 2024 Jan 12;[EPub Ahead of Print], A Tjokrowidjaja, ML Friedlander, JA Ledermann, RL Coleman, MR Mirza, UA Matulonis, E Pujade-Lauraine, SJ Lord, CL Scott, S Goble, W York, CK LeeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.